Back to search
FDAFDA · Food and drugs·Recall number Z-1484-2024

LVP Software of the Ivenix Infusion System (IIS), Version 5.8.0.

Published April 17, 2024 · Recall initiated: March 7, 2024

Summary

FDA records medical device Class I recall Z-1484-2024, published April 17, 2024 and initiated March 7, 2024. Recalling firm: Fresenius Kabi USA, LLC; Status: Ongoing; Reported quantity: 17 units; Lot: Product LVP-SW-0004; UDI-DI 00811505030122. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Software has anomalies that have the potential to cause underdose, overdose, or delay in therapy which could lead to serious patient harm or death.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Fresenius Kabi USA, LLC
Distributor
US Distribution: CA, CO, ID, MI, NE, NJ, NV, OK, TX, UT, VA, WA, & WI.
Lot
Product LVP-SW-0004; UDI-DI 00811505030122.
Risk classification
Class I
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was LVP Software of the Ivenix Infusion System (IIS), Version 5.8.0. recalled?

Yes. FDA published recall Z-1484-2024 on April 17, 2024. Reported hazard: Software has anomalies that have the potential to cause underdose, overdose, or delay in therapy which could lead to serious patient harm or death.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit